Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis

Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer’s Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of dementia worldwide. The limited pharmacological approaches based on cholinesterase inhibitors only provide symptomatic relief to AD patients. Moreover, the adverse side effects such as nausea, vomiting, los...

Full description

Bibliographic Details
Main Authors: Sumera Zaib, Rubina Munir, Muhammad Tayyab Younas, Naghmana Kausar, Aliya Ibrar, Sehar Aqsa, Noorma Shahid, Tahira Tasneem Asif, Hashem O. Alsaab, Imtiaz Khan
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Molecules
Subjects:
quinoline
thiosemicarbazone
molecular design
hybridization
Alzheimer’s disease
neurodegeneration
Online Access:https://www.mdpi.com/1420-3049/26/21/6573

Internet

https://www.mdpi.com/1420-3049/26/21/6573

Similar Items